Literature DB >> 10194496

Endothelial-dependent vasodilation is associated with increases in the phosphorylation of a small heat shock protein (HSP20).

H Jerius1, D R Karolyi, J S Mondy, A Beall, D Wootton, D Ku, S Cable, C M Brophy.   

Abstract

PURPOSE: Increases in the phosphorylation of a small heat shock protein (HSP20) are associated with cyclic nucleotide-dependent vasorelaxation. The effect of pressure and flow on vessel diameter was studied. We hypothesized that physiologic conditions that induce vasorelaxation would lead to increases in HSP20 phosphorylation.
METHODS: Flow-dependent changes in vessel diameter, at different intraluminal pressures, were measured with a laser optical micrometer in intact bovine carotid arteries. Experiments were performed in the presence and absence of norepinephrine (10(-5) mol/L). Increases in the phosphorylation of HSP20 were determined with isoelectric focusing immunoblots.
RESULTS: The increase in vessel diameter was most significant at low intraluminal pressures (20 mm Hg), high flow rates (200 mL/min), and in the presence of the vasoconstrictor norepinephrine (10(-5) mol/L). The addition of methylene blue (a guanylate cyclase inhibitor) completely inhibited flow-induced vasodilation. Under conditions in which maximal flow induced vasodilation occurred, there were significant increases in the phosphorylation of HSP20.
CONCLUSION: Flow-dependent vasodilation in isolated perfused segments of bovine carotid arteries was maximal when the intraluminal pressures were low and when the vessels were precontracted with norepinephrine. Flow-dependent vasodilation was inhibited by methylene blue and was associated with increases in the phosphorylation of HSP20, suggesting that the vasodilation was mediated by endothelial production of nitric oxide.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10194496     DOI: 10.1016/s0741-5214(99)70314-9

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  8 in total

Review 1.  The small heat shock protein, HSPB6, in muscle function and disease.

Authors:  Catherine M Dreiza; Padmini Komalavilas; Elizabeth J Furnish; Charles R Flynn; Michael R Sheller; Christopher C Smoke; Luciana B Lopes; Colleen M Brophy
Journal:  Cell Stress Chaperones       Date:  2009-07-01       Impact factor: 3.667

2.  cGMP-mediated phosphorylation of heat shock protein 20 may cause smooth muscle relaxation without myosin light chain dephosphorylation in swine carotid artery.

Authors:  C M Rembold; D B Foster; J D Strauss; C J Wingard; J E Eyk
Journal:  J Physiol       Date:  2000-05-01       Impact factor: 5.182

3.  Heat-shock response is associated with enhanced contractility of vascular smooth muscle in isolated rat aorta.

Authors:  In Kyeom Kim; Tae-Gyu Park; Yeung Hyen Kim; Jun Woo Cho; Bong-Seok Kang; Choong-Young Kim
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2004-03-04       Impact factor: 3.000

Review 4.  Cell-permeant peptide inhibitors of vasospasm and intimal hyperplasia.

Authors:  Michael J Osgood; Charles R Flynn; Padmini Komalavilas; Colleen Brophy
Journal:  Vascular       Date:  2012-10-26       Impact factor: 1.285

5.  Phospholemman does not participate in forskolin-induced swine carotid artery relaxation.

Authors:  M K Meeks; S Han; A L Tucker; C M Rembold
Journal:  Physiol Res       Date:  2007-10-11       Impact factor: 1.881

6.  Force suppression and the crossbridge cycle in swine carotid artery.

Authors:  Christopher M Rembold
Journal:  Am J Physiol Cell Physiol       Date:  2007-05-23       Impact factor: 4.249

7.  Impact of exercise and metabolic disorders on heat shock proteins and vascular inflammation.

Authors:  Earl G Noble; Garry X Shen
Journal:  Autoimmune Dis       Date:  2012-12-17

8.  Monomeric 14-3-3ζ has a chaperone-like activity and is stabilized by phosphorylated HspB6.

Authors:  Nikolai N Sluchanko; Natalya V Artemova; Maria V Sudnitsyna; Irina V Safenkova; Alfred A Antson; Dmitrii I Levitsky; Nikolai B Gusev
Journal:  Biochemistry       Date:  2012-07-25       Impact factor: 3.162

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.